Grant: Operating Grant -PA: Inst of Circulatory and Respiratory Health - Bridge Funding
Université Laval
$100,000.00
A critical role of progesterone for development of respiratory control system: towards a new therapeutic tool for apnea of prematurity
EF 2008-09
Résumé
Apneas of prematurity are the most important cause of morbidity in preterm neonates. Caffeine is routinely used to alleviate apneas and this treatment can last for several weeks. However, recent studies in rats raised important questions about thelong-term safety of neonatal caffeine treatment. Several lines of evidence suggest that in preterm neonates, chronic deprivation from placental progesterone exposure contributes to the development of apneas. Recent results from our laboratory are consistent with this hypothesis, thereby making progesterone replacement therapy an appealing therapeutic avenue. During a sudden drop of arterial oxygen (hypoxia, such as occuring during prolonged apneas), a rapid increase in breathing is vital and requires activation of the carotid bodies (the main peripheral chemoreceptors). Preliminary results obtained using an in-vitro carotid body preparation from newborn rats show that treatment with progesterone or its antagonist mifepristone increases and decrease carotid body function, respectively. Furthermore, rat pups treated with mefiprestone show a drastically reduced response to hypoxia. With respect to the long-term safety of this potential treatment, preliminary data show that adult rats previously subjected to postnatal progesterone have a normal breathing pattern. These results are important because they highlight both the short-termefficiency and the long-term safety of progesterone as an alternative treatment for apneas of prematurity. The proposed experiments will shed new light on a potentially important mechanism involved in the maturation of the respiratory control system. Given the growing number of premature births in Canada, this basic research has the potential to have a significant
clinical impact as it will provide the basis for the development of new approaches in the treatment of apneas of prematurity.
Programme
Operating Grant -PA: Inst of Circulatory and Respiratory Health - Bridge Funding
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
179362
Name
Joseph Vincent
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Respiratory System
Projecttitle
A critical role of progesterone for development of respiratory control system: towards a new therapeutic tool for apnea of prematurity
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant -PA: Inst of Circulatory and Respiratory Health - Bridge Funding
Keyworddelim
Apneas; Development; Newborn; Peripheral Chemoreceptors; Plasticity; Progesterone
Abstract
Apneas of prematurity are the most important cause of morbidity in preterm neonates. Caffeine is routinely used to alleviate apneas and this treatment can last for several weeks. However, recent studies in rats raised important questions about thelong-term safety of neonatal caffeine treatment. Several lines of evidence suggest that in preterm neonates, chronic deprivation from placental progesterone exposure contributes to the development of apneas. Recent results from our laboratory are consistent with this hypothesis, thereby making progesterone replacement therapy an appealing therapeutic avenue. During a sudden drop of arterial oxygen (hypoxia, such as occuring during prolonged apneas), a rapid increase in breathing is vital and requires activation of the carotid bodies (the main peripheral chemoreceptors). Preliminary results obtained using an in-vitro carotid body preparation from newborn rats show that treatment with progesterone or its antagonist mifepristone increases and decrease carotid body function, respectively. Furthermore, rat pups treated with mefiprestone show a drastically reduced response to hypoxia. With respect to the long-term safety of this potential treatment, preliminary data show that adult rats previously subjected to postnatal progesterone have a normal breathing pattern. These results are important because they highlight both the short-termefficiency and the long-term safety of progesterone as an alternative treatment for apneas of prematurity. The proposed experiments will shed new light on a potentially important mechanism involved in the maturation of the respiratory control system. Given the growing number of premature births in Canada, this basic research has the potential to have a significant
clinical impact as it will provide the basis for the development of new approaches in the treatment of apneas of prematurity.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Joseph, Vincent
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~